Joshua D. Thomas

524 total citations
32 papers, 263 citations indexed

About

Joshua D. Thomas is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, Joshua D. Thomas has authored 32 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Organic Chemistry. Recurrent topics in Joshua D. Thomas's work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (9 papers) and Advancements in Transdermal Drug Delivery (4 papers). Joshua D. Thomas is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (9 papers) and Advancements in Transdermal Drug Delivery (4 papers). Joshua D. Thomas collaborates with scholars based in United States. Joshua D. Thomas's co-authors include Kenneth B. Sloan, Timothy B. Lowinger, Elena Ter‐Ovanesyan, Dmitry R. Gumerov, LiuLiang Qin, Natalya D. Bodyak, Mao Yin, Bangmin Zhu, Charles E. Hammond and Justin H. Schripsema and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Joshua D. Thomas

29 papers receiving 249 citations

Peers

Countries citing papers authored by Joshua D. Thomas

Since Specialization

Citations

This map shows the geographic impact of Joshua D. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua D. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua D. Thomas more than expected).

Fields of papers citing papers by Joshua D. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua D. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua D. Thomas. The network helps show where Joshua D. Thomas may publish in the future.

Co-authorship network of co-authors of Joshua D. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua D. Thomas. A scholar is included among the top collaborators of Joshua D. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua D. Thomas. Joshua D. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates 2024 ·Molecular Cancer Therapeutics ·Joshua D. Thomas, (unknown), Mao Yin, Natalya D. Bodyak, (unknown), Marina Protopopova, (unknown), Brian Jones, Liping Yang, Daniel Custar, (unknown), Damon R. Demady, Scott D. Collins, Ling Xu, (unknown), LiuLiang Qin, Elena Ter‐Ovanesyan, Marc Damelin, Dorin Toader, Timothy B. Lowinger	0
2	EARLY ADMINISTRATION OF ANAKINRA, CORTICOSTERIODS, AND REMDESIVIR FOR THE MANAGEMENT OF A PATIENT WITH CARDIOGENIC SHOCK AND CARDIAC TAMPONADE FROM SUSPECTED COVID-INDUCED FULMINANT MYOCARDITIS 2024 ·Journal of the American College of Cardiology ·Joshua D. Thomas, (unknown), (unknown), Juan M. Aranda, (unknown), (unknown), (unknown)	0
3	Patient–specific hemodynamic modeling to optimize LVAD speed and right heart health 2024 ·SHILAP Revista de lepidopterología ·Mustafa M. Ahmed, (unknown), (unknown), Joshua D. Thomas, Mohammad Al‐Ani, (unknown), Juan Vilaro, Juan Aranda, Venkat Keshav Chivukula	0
4	Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates 2023 ·Journal of Medicinal Chemistry ·Jeremy R. Duvall, Joshua D. Thomas, Raghida A. Bukhalid, (unknown), K. W. Bentley, Scott D. Collins, Timothy K. Eitas, Brian Jones, (unknown), (unknown), Marina Protopopova, Soumya S. Ray, Elena Ter‐Ovanesyan, Ling Xu, Liping Yang, (unknown), Marc Damelin, Dorin Toader, Timothy B. Lowinger	32
5	Discovery of novel polyamide-pyrrolobenzodiazepine hybrids for antibody-drug conjugates 2022 ·Bioorganic & Medicinal Chemistry Letters ·Joshua D. Thomas, (unknown), Mao Yin, Natalya D. Bodyak, Dmitry R. Gumerov, (unknown), (unknown), Brian Jones, Marina Protopopova, LiuLiang Qin, (unknown), Damon R. Demady, Timothy B. Lowinger	3
6	Evaluating the baseline auscultation abilities of second-year chiropractic students using simulated patients and high-fidelity manikin simulators: A pilot study 2022 ·Journal of Chiropractic Education ·(unknown), (unknown), (unknown), Joshua D. Thomas, (unknown)	1
7	Abstract 2114: Tumor cell-targeted STING-agonist antibody-drug conjugates achieve potent anti-tumor activity by delivering STING agonist specifically to tumor cells andFcγRI-expressing subset of myeloid cells 2022 ·Cancer Research ·Naniye Mallı Cetinbas, (unknown), Travis Monnell, (unknown), K. W. Bentley, Susan M. Clardy, (unknown), (unknown), Marina Protopopova, (unknown), Joshua D. Thomas, (unknown), Dorin Toader, Jeremy R. Duvall, Raghida A. Bukhalid, Marc Damelin, Timothy B. Lowinger	6
8	620 Tumor cell-intrinsic STING pathway is activated in the presence of cues from immune cells and contributes to the anti-tumor activity of tumor cell-targeted STING agonist antibody-drug conjugates 2020 ·SHILAP Revista de lepidopterología ·Naniye Mallı Cetinbas, Travis Monnell, Winnie Lee, (unknown), Chen‐Ni Chin, Pamela Shaw, Kelly L. Slocum, LiuLiang Qin, (unknown), K. W. Bentley, Susan M. Clardy, Brian Jones, (unknown), Joshua D. Thomas, Rebecca Mosher, Dorin Toader, Jeremy R. Duvall, Raghida A. Bukhalid, Marc Damelin, Timothy B. Lowinger	3
9	Immunomodulatory T cell death associated gene-8 (TDAG8) receptor in depression-associated behaviors 2019 ·Physiology & Behavior ·(unknown), Lauren L. Vollmer, Rebecca Ahlbrand, Joshua D. Thomas, A. Scott Winter, Ian Lewkowich, Renu Sah	2
10	A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy 2015 ·Cancer Research ·(unknown), Mao Yin, Natalya D. Bodyak, (unknown), Joshua D. Thomas, Charles E. Hammond, LiuLiang Qin, Bangmin Zhu, Dmitry R. Gumerov, Elena Ter‐Ovanesyan, (unknown), Timothy B. Lowinger	73
11	Abstract LB-231: A novel, highly potent HER2-targeted antibody-drug conjugate (ADC) for the treatment of low HER2-expressing tumors and combination with trastuzumab-based regimens in HER2-driven tumors 2015 ·Cancer Research ·Donald A. Bergstrom, Natalya D. Bodyak, (unknown), Peter U. Park, Michael J. DeVit, Mao Yin, Laura L. Poling, Joshua D. Thomas, Dmitry R. Gumerov, Dongmei Xiao, Elena Ter‐Ovanesyan, LiuLiang Qin, (unknown), (unknown), Timothy B. Lowinger	12
12	Harnessing the Fcμ Receptor for Potent and Selective Cytotoxic Therapy of Chronic Lymphocytic Leukemia 2014 ·Cancer Research ·Bérengère Vire, Martin Skarzynski, Joshua D. Thomas, (unknown), Alexandre David, Georg Aue, Terrence R. Burke, Christoph Rader, Adrian Wiestner	12
13	Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8⁺T Cells and TNF Receptor Superfamily Member 1a on Non-CD8⁺T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection 2014 ·The Journal of Infectious Diseases ·(unknown), Joshua D. Thomas, Weidang Li, (unknown), Justin H. Schripsema, Kyle H. Ramsey, Ashlesh K. Murthy	31
14	Evaluation of alkyloxycarbonyloxymethyl (AOCOM) ethers as novel prodrugs of phenols for topical delivery: AOCOM prodrugs of acetaminophen 2008 ·International Journal of Pharmaceutics ·Joshua D. Thomas, Kenneth B. Sloan	9
15	Reaction of α-(n-Alkylcarbonyloxy)alkyl (ACOA) Halides with 4-Hydroxyacetanilide and 2,2,5,7,8-Pentamethyl-6-chromanol: The Effect of Steric Hindrance on Reaction Path 2008 ·Synthesis ·Kenneth B. Sloan, Joshua D. Thomas	2
16	In vitro evaluation of alkylcarbonyloxymethyl (ACOM) ethers as novel prodrugs of phenols for topical delivery: ACOM prodrugs of acetaminophen 2007 ·International Journal of Pharmaceutics ·Joshua D. Thomas, Kenneth B. Sloan	13
17	The effect of water solubility of solutes on their flux through human skin in vitro: An extended Flynn database fitted to the Roberts–Sloan equation 2007 ·International Journal of Pharmaceutics ·Joshua D. Thomas, Susruta Majumdar, Scott Wasdo, Antara Majumdar, Kenneth B. Sloan	13
18	α-(1H-Imidazol-1-yl)alkyl (IMIDA) carboxylic acid esters as prodrugs of carboxylic acid containing drugs 2007 ·Tetrahedron Letters ·Susruta Majumdar, (unknown), (unknown), (unknown), Joshua D. Thomas, Kenneth B. Sloan	1
19	IMPROVING THE TOPICAL DELIVERY OF PHENOL-CONTAINING DRUGS: AN ALKYLCARBONYLOXYMETHYL AND ALKYLOXYCARBONYLOXYMETHYL PRODRUG APPROACH 2006 ·Joshua D. Thomas	2
20	Quantitation of pretransplantation immune responsiveness by in vitro T-cell testing. 1977 ·PubMed ·Frédéric Thomas, G Méndez-Picón, Joshua D. Thomas, Lee Hm	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact